Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

Industry Trends

Clinical Trial Trends

Disease Area Trends

Recent Tweets

Sermonix Pharmaceuticals reports 'Menopause' journal article on Oral Lasofoxifene's impact on Vaginal Atrophy in Postmenopausal Women.

More Info: https://pryzm.ozmosi.com/product/1172 $XBI $IBB $XPH $PPH

$ATOS Atossa Therapeutics expands research agreement with Weill Cornell Medicine to study synergy between ADCs and (Z)-Endoxifen.

More Info: https://pryzm.ozmosi.com/product/32506 $XBI $IBB $XPH $PPH

$NKGN NKGen Biotech received FDA approval for IND application of SNK01 NK cell therapy in Parkinson's Disease.

More Info: https://pryzm.ozmosi.com/product/20002 $XBI $IBB $XPH $PPH

Dermavant's sNDA for VTAMA® Cream, 1% to treat Atopic Dermatitis in adults and children 2 years and older has been accepted by the FDA.

More Info: https://pryzm.ozmosi.com/product/19085 $XBI $IBB $XPH $PPH

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762